Home > Boards > US Listed > Medical - Healthcare >

Mylan Inc. (MYL)

MYL RSS Feed
Add MYL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/28/2019 10:11:35 AM - Followers: 14 - Board type: Free - Posts Today: 0
MYL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MYL News: Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting 10/21/2019 04:00:00 PM
MYL News: Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission 09/27/2019 10:25:00 AM
MYL News: Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer 09/17/2019 09:30:00 AM
MYL News: Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) 09/03/2019 09:56:01 AM
MYL News: Statement of Changes in Beneficial Ownership (4) 08/19/2019 07:30:46 PM
News News Alert: Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting 10/21/2019 04:00:00 PM
PostSubject
#152   F.D.A. removes Mylan Inc. Ascorbic Acid Injection from CloneKook 08/28/19 10:11:35 AM
#151   Transcript of MYL-PFE/Upjohn CC: DewDiligence 07/30/19 05:39:03 PM
#150   Sold my $21 call100 sorkin 07/30/19 04:37:24 PM
#149  Restored News: $MYL Revenues For Connected Medical Device Market whytestocks 07/30/19 08:50:26 AM
#148   The merger is fully taxable for MYL shareholders, DewDiligence 07/29/19 01:09:37 PM
#147   Good read (IMO) on the PFE/Upjohn deal: DewDiligence 07/29/19 01:07:45 PM
#146   The merger closing won't happen until mid 2020. DewDiligence 07/29/19 01:06:24 PM
#145   Looks like we’ll be getting a dividend once finishgreen 07/29/19 12:59:44 PM
#144   News: $MYL Mylan and Upjohn, a Division of whytestocks 07/29/19 12:33:04 PM
#143   News: $MYL Mylan Reports Second Quarter 2019 Results whytestocks 07/29/19 12:20:39 PM
#142   PFE/Upjohn merges with MYL, forming new US-based company: DewDiligence 07/29/19 09:26:25 AM
#141   Mylan NV $MYL Technical Signal Says Upside Near Term ITMS 05/16/19 01:26:14 PM
#140   Drug price fixing, list of defendants, JLS 05/14/19 07:40:23 PM
#139   MYL 1Q19 CC transcript: DewDiligence 05/08/19 11:15:45 AM
#138   Another 10-20% downside! Terrible earnings and guidance sorkin 05/08/19 06:12:19 AM
#137   MYL plunges to 7-year low on 1Q19 results: DewDiligence 05/07/19 12:23:24 PM
#136   MYL 4Q18 results: DewDiligence 02/26/19 05:12:04 PM
#135   MYL launches generic Advair at 70% list-price discount DewDiligence 02/12/19 11:48:33 AM
#134   MYL’s own PR on Wixela Inhub—the name they’re DewDiligence 01/31/19 03:29:56 PM
#133   Congratulations , Mylan , this is a significant approval. Fortune 500 01/31/19 07:30:12 AM
#132   FDA approves MYL's generic Advair—the first US generic DewDiligence 01/30/19 04:24:04 PM
#130   Yes, Myl has spent money to make money Fortune 500 01/29/19 08:54:34 PM
#129   One reason MYL trades at a low valuation DewDiligence 01/29/19 07:54:49 PM
#128   You are, of course, correct. However, Fortune 500 01/29/19 06:54:21 PM
#127   MYL did not acquire Mapi Pharma—they acquired the DewDiligence 01/29/19 06:46:55 PM
#126   Oh! What is MAPI Pharma ? Fortune 500 01/29/19 06:35:33 PM
#125   MYL doesn't acquire pre-commercial-stage companies. DewDiligence 01/29/19 06:23:55 PM
#124   IIMO, It would be terrific if Mylan acquired Fortune 500 01/29/19 06:18:46 PM
#123   Barron’s like MYL based on rock-bottom valuation: DewDiligence 01/05/19 12:35:05 PM
#122   MYL 3Q18 results: DewDiligence 11/05/18 04:54:51 PM
#121   http://newsroom.mylan.com/2018-08-08-Statement-from-Mylans-Board-of-Directors dangerM 08/08/18 04:56:41 PM
#120   MYL 2Q18 items… DewDiligence 08/08/18 10:15:28 AM
#119   $INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves SpotOnTrade 07/20/18 10:53:35 AM
#118   The Mylan $MYL Chart Pattern Suggests Lower Ahead ITMS 07/17/18 12:23:37 PM
#117   ABBV settles US Humira patent with MYL—7/31/23 launch DewDiligence 07/17/18 10:31:56 AM
#116   Mylan Drops After FDA Finds Deficiencies In Its ITMS 06/14/18 12:26:45 PM
#115   FDA approves MYL’s Fulphila—a Neulasta FoB: DewDiligence 06/04/18 05:48:42 PM
#114   MYL 1Q18 PR and CC slides… DewDiligence 05/09/18 08:39:50 AM
#113   Slide set from today's Investor Day (108 pages): DewDiligence 04/11/18 07:48:48 PM
#112   MYL acquires European rights to Fujifilm’s Humira FoB: #msg-139952524. DewDiligence 04/11/18 10:09:49 AM
#111   MYL in-licenses Copaxone knock-off with monthly dosing: #msg-139933652. DewDiligence 04/10/18 03:09:19 PM
#110   MYL Investor Day—4/11/18, 1-4pm ET: DewDiligence 03/21/18 12:07:51 PM
#109   MYL 4Q17 CC slides: DewDiligence 03/05/18 12:27:58 PM
#108   MYL launches two HIV FDCs in US market: #msg-138972875. DewDiligence 03/02/18 10:53:28 AM
#107   More on the same topic: #msg-138939208. DewDiligence 03/01/18 07:36:27 PM
#106   MYL 4Q17 financials: DewDiligence 03/01/18 07:34:29 PM
#105   Additional commentary on RVNC/MYL deal: DewDiligence 03/01/18 10:37:50 AM
#104   RVNC, MYL collaborate on Botox biosimilar: DewDiligence 02/28/18 06:34:01 PM
#103   Seven things Trump's $500bn spending splurge tells us p0 02/10/18 04:43:57 AM
#102   TEVA drops Copaxone lawsuit against MYL on ‘775 DewDiligence 12/11/17 06:47:38 PM
PostSubject